Business
Digital diet and wellness company Noom led last quarter's funding with $540 million in Series F investments.
Also: Entos works to improve drug development after closing its Series A round and Castor plans to build out its decentralized clinical trial platform with a $45 million investment.
Once combined, the company will operate as HeartFlow Group and trade on the NYSE under symbol HFLO.
The proceeds will be used to fund the clinical development of MyopiaX, the company's lead product in childhood myopia.
The Israeli company now has a total of $9 million in venture funding.
This brings the company's total raise to $140 million.
The company’s production studio has created over 2,000 original videos that span a variety of conditions and procedures.
Clinical communication tool used in the NHS saved patient photos on smartphones.
Also: Philips and Cognizant team up to develop digital health solutions and MindMed taps Datavant to improve access to real-world data.
The company is planning on using the new funds to expand its library and build more capabilities.